Open-Label, 8-Week Trial of Olanzapine and Risperidone for the Treatment of Bipolar Disorder in Preschool-Age Children
- 1 October 2005
- journal article
- clinical trial
- Published by Elsevier in Biological Psychiatry
- Vol. 58 (7) , 589-594
- https://doi.org/10.1016/j.biopsych.2005.03.019
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- An Open-Label Trial of Risperidone in Children and Adolescents with Bipolar DisorderJournal of Child and Adolescent Psychopharmacology, 2005
- Efficacy of Atypical Antipsychotics in Mood DisordersJournal of Clinical Psychopharmacology, 2003
- Discriminative Validity of a Parent Version of the Young Mania Rating ScaleJournal of the American Academy of Child & Adolescent Psychiatry, 2002
- Factor Structure of the Young Mania Rating Scale for Use With Youths Ages 5 to 17 YearsJournal of Clinical Child & Adolescent Psychology, 2002
- Double-Blind, Placebo-Controlled Study of Risperidone for the Treatment of Disruptive Behaviors in Children With Subaverage IntelligenceAmerican Journal of Psychiatry, 2002
- Psychiatric Comorbidity and Functioning in Clinically Referred Preschool Children and School-Age Youths With ADHDJournal of the American Academy of Child & Adolescent Psychiatry, 2002
- A Prospective Open-Label Treatment Trial of Olanzapine Monotherapy in Children and Adolescents with Bipolar DisorderJournal of Child and Adolescent Psychopharmacology, 2001
- New subscales for an anchored version of the Brief Psychiatric Rating Scale: Construction, reliability, and validity in acute psychiatric admissions.Psychological Assessment, 2001
- Historical Development and Present Status of the Schedule for Affective Disorders and Schizophrenia for School-Age Children (K-SADS)Journal of the American Academy of Child & Adolescent Psychiatry, 2000
- A Rating Scale for Mania: Reliability, Validity and SensitivityThe British Journal of Psychiatry, 1978